MicroRNA-200c Overexpression Inhibits Tumorigenicity and Metastasis of CD117+CD44+ Ovarian Cancer Stem Cells by Regulating Epithelial-Mesenchymal Transition

Journal of Ovarian Research - United Kingdom
doi 10.1186/1757-2215-6-50
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-573 Inhibits Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

The microRNA miR-34a Inhibits Prostate Cancer Stem Cells and Metastasis by Directly Repressing CD44

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

MDM2 Promotes Epithelial–mesenchymal Transition and Metastasis of Ovarian Cancer SKOV3 Cells

British Journal of Cancer
Cancer ResearchOncology
2017English

CD133+ Ovarian Cancer Stem-Like Cells Promote Non-Stem Cancer Cell Metastasis via CCL5 Induced Epithelial-Mesenchymal Transition

Oncotarget
Oncology
2015English

miR-200C Inhibits Growth of Uterine Carcinosarcoma Cells by Driving a Mesenchymal-To-Epithelial Transition

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

P08: CD44 Promotes Epithelial‐mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin‐1 Expression and Predicts Poor Survival of Ovarian Cancer

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2019English

MicroRNA-298 Inhibits Malignant Phenotypes of Epithelial Ovarian Cancer by Regulating the Expression of EZH2

Oncology Letters
Cancer ResearchOncology
2016English

Downregulation of CHIP Promotes Ovarian Cancer Metastasis by Inducing Snail‐mediated Epithelial‐mesenchymal Transition

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy